LifeMD, Inc. to Announce Fourth Quarter, Full Year 2022 Financial Results on March 22, 2023
March 07 2023 - 08:00AM
GlobeNewswire Inc.
LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient
telehealth company, today announced that it will report its
financial results for the fourth quarter and full year ended
December 31, 2022 after the market close on Wednesday, March 22,
2023. Management will also host a conference call with investors to
discuss financial results and provide a corporate update at 4:30pm
Eastern Time.
Conference
Call & Webcast Details: |
Date: |
Wednesday, March 22nd |
Time: |
4:30pm ET |
Toll Free: |
1-877-704-4453 |
International: |
1-201-389-0920 |
Conference ID: |
13736906 |
Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1602716&tp_key=5d40c4c9f6 |
About LifeMDLifeMD is a 50-state
direct-to-patient telehealth company with a portfolio of brands
that offer virtual primary care, diagnostics, and specialized
treatment for men’s and women’s health, allergy & asthma, and
dermatological conditions. By leveraging its proprietary technology
platform, 50-state affiliated medical group, and nationwide
mail-order pharmacy network, LifeMD is increasing access to
top-notch healthcare that is affordable to anyone. To learn more,
go to LifeMD.com.
Cautionary Note Regarding Forward Looking
StatementsThis news release includes forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended; Section 21E of the Securities Exchange Act of
1934, as amended; and the safe harbor provision of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking
statements contained in this news release may be identified by the
use of words such as: “believe,” “expect,” “anticipate,” “project,”
“should,” “plan,” “will,” “may,” “intend,” “estimate,” predict,”
“continue,” and “potential,” or, in each case, their negative or
other variations or comparable terminology referencing future
periods. Examples of forward-looking statements include, but are
not limited to, statements regarding our financial outlook and
guidance, short and long-term business performance and operations,
future revenues and earnings, regulatory developments, legal events
or outcomes, ability to comply with complex and evolving
regulations, market conditions and trends, new or expanded products
and offerings, growth strategies, underlying assumptions, and the
effects of any of the foregoing on our future results of operations
or financial condition.
Forward-looking statements are not historical facts and are not
assurances of future performance. Rather, these statements are
based on our current expectations, beliefs, and assumptions
regarding future plans and strategies, projections, anticipated and
unanticipated events and trends, the economy, and other future
conditions, including the impact of any of the aforementioned on
our future business. As forward-looking statements relate to the
future, they are subject to inherent risk, uncertainties, and
changes in circumstances and assumptions that are difficult to
predict, including some of which are out of our control.
Consequently, our actual results, performance, and financial
condition may differ materially from those indicated in the
forward-looking statements. These risks and uncertainties include,
but are not limited to, “Risk Factors” identified in our filings
with the Securities and Exchange Commission, including, but not
limited to, our most recently filed Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q, and any amendments thereto. Even if
our actual results, performance, or financial condition are
consistent with forward-looking statements contained in such
filings, they may not be indicative of our actual results,
performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based
on information currently available to us as of the date on which
this release is made. We undertake no obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise, except as may be required
under applicable law or regulation.
Company Contact LifeMD, Inc. Marc Benathen,
CFOmarc@lifemd.com
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From May 2023 to Jun 2023
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From Jun 2022 to Jun 2023